Cidara Therapeutics, Inc.
(NASDAQ : CDTX)

( )
CDTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 1.14%67.561.0%$1024.31m
BIIBBiogen, Inc. -0.37%333.001.5%$704.38m
AMGNAmgen, Inc. 0.20%223.481.3%$582.04m
ILMNIllumina, Inc. 2.59%298.923.5%$424.29m
REGNRegeneron Pharmaceuticals, Inc. 0.19%399.552.6%$378.07m
VRTXVertex Pharmaceuticals, Inc. 1.55%243.821.9%$358.57m
ALXNAlexion Pharmaceuticals, Inc. -0.83%102.562.0%$204.52m
EXASEXACT Sciences Corp. 3.61%98.1824.0%$177.12m
AAgilent Technologies, Inc. 0.43%85.841.6%$157.99m
SGENSeattle Genetics, Inc. -0.13%118.076.1%$115.03m
MRNAModerna, Inc. -0.24%19.000.0%$108.13m
INCYIncyte Corp. 0.51%78.452.5%$101.70m
SRPTSarepta Therapeutics, Inc. 0.31%125.4214.6%$97.52m
BMRNBioMarin Pharmaceutical, Inc. 0.87%89.014.3%$96.71m
XLRNAcceleron Pharma, Inc. -0.48%93.666.1%$94.41m

Company Profile

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.